Protocol for a Cross-Sectional Study: Effects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone on Offspring Neurocognitive Development and Behavior (MS-Children)

Protocol for a Cross-Sectional Study: Effects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone on Offspring Neurocognitive Development and Behavior (MS-Children)

IntroductionMultiple Sclerosis (MS) is the most common neuroimmunological disease in women of childbearing age. Current MS therapy consists of immunomodulatory relapse prevention with disease-modifying therapies (DMTs) and acute relapse therapy with the synthetic glucocorticoid (GC) methylprednisolo...

Full description

Bibliographic Details
Main Authors: Valeska Kozik, Matthias Schwab, Sandra Thiel, Kerstin Hellwig, Florian Rakers, Michelle Dreiling
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Neurology
Subjects:
Multiple sclerosis
glucocorticoids
methylprednisolone
cognition
pituitary-adrenal axis
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.830057/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.830057/full

Similar Items